seroquel Resources | BNET
On MP3.com: Video Interview with Blixa Bargeld

Resources

1 Resources for

seroquel

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

AstraZeneca Bolstered By Seroquel Patent Victory
By Ben Hirschler LONDON (Reuters UK) - AstraZeneca AZN shares rose nearly 5 percent on Wednesday after the group won a key U.S. patent battle over its second-biggest selling drug, Seroquel, for schizophrenia and bipolar disorder. The court decision to award summary judgment in its favour,...
Tags: AstraZeneca Plc., Patent, Seroquel, Noven Pharmaceuticals Inc., Oukbs
News items 2008-07-02

Additional Resources

An eye for detail
Dr. Rob Long--I was greatly distressed to learn that your client Hillary Clinton had stabbed you in the eye with a pencil. As I'm sure you know, the best predictor of violent behavior is past violent behavior, so I was surprised at your lack of precaution with this particular woman....
Articles 2008-07-14
Main movers
AInforma 427.5p (up 49.25p, 13.02 per cent) Confirms 506p-per- share approach by Providence consortium. AAstraZeneca 2,233p (up 103p, 4.84 per cent) Summary judgment in Seroquel dispute. ATaylor Nelson Sofres 225p (up 5.5p, 2.51 per cent) WPP bid speculation; Takeover Panel sets 9 July deadline....
Articles 2008-07-03
Business Digest
AstraZeneca wins Seroquel case *The Anglo-Swedish pharmaceutical group AstraZeneca received a boost yesterday when an American court upheld its patent over the $4bn- (2bn) a- year schizophrenia and bipolar blockbuster Seroquel. The New Jersey District Court awarded AstraZeneca summary judgment in the face of...
Articles 2008-07-03
Summary Judgment Granted for SEROQUEL® Patent Litigation
WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as...
Articles 2008-07-01
Teva Provides Update on Generic Seroquel® Litigation
JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of New Jersey has issued a decision in its litigation over the Company's Abbreviated New Drug Application ANDA to market its generic version of AstraZeneca's Seroquel[R] Quetiapine Tablets. The Court granted summary...
Articles 2008-07-01
A Cluster of Veterans' Deaths; By Fred A. Baughman Jr., MD
EL CAJON, Calif., June 20 /PRNewswire/ -- Recently four Charleston, WV-area veterans -- Derek Johnson, 22, Andrew White, 23, Eric Layne, 29, and Nicholas Endicott, with "Post Traumatic Stress Disorder" PTSD, treated with the Paxil, Klonopin, and Seroquel -- died in their sleep. All were said to be...
Articles 2008-06-20
Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca
AstraZeneca's CEO to be Deposed in London on Friday, June 20, 2008 NEW YORK, June 19 /PRNewswire/ -- Weitz & Luxenberg, PC, one of the leading plaintiffs' litigation law firms in America, filed a lawsuit today against pharmaceutical giant AstraZeneca on behalf of a New York City...
Articles 2008-06-19
Main movers
ALondon Stock Exchange 1,081p (up 47p, 4.55 per cent) International IPOs in London raised $4.2bn (2.2bn) last month. AAnglo American 3,389p (up 34p, 0.92 per cent) Mining sector strength. AAstraZeneca 2,130p (up 39p, 1.87 per cent) FDA approves Seroquel maintenance treatment in bipolar...
Articles 2008-05-15
AstraZeneca says US watchdog okays bipolar drug
LONDON AFP — Anglo-Swedish pharmaceuticals giant AstraZeneca said Wednesday that the US Food and Drug Administration has approved the use of its Seroquel drug to treat bipolar I disorder. According to AstraZeneca, bipolar I disorder is a lifelong psychiatric condition characterised by manic or mixed mood episodes, interspersed...
Articles 2008-05-14
FDA Approves AstraZeneca's Seroquel® for Maintenance Treatment in Bipolar Disorder
WILMINGTON, Del., May 14 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the U.S. Food and Drug Administration FDA has approved SEROQUELR quetiapine fumarate tablets for the maintenance treatment of patients with bipolar I disorder, as adjunct therapy to lithium or divalproex. SEROQUEL is approved by the FDA for the...
Articles 2008-05-14
AstraZeneca Submits sNDA for SEROQUEL XR™ for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
WILMINGTON, Del., May 8 /PRNewswire-FirstCall/ -- AstraZeneca today announced the submission of a supplemental New Drug Application sNDA to the U.S. Food and Drug Administration FDA for SEROQUEL XRTM quetiapine fumarate Extended-Release Tablets to seek approval for the treatment of generalized anxiety disorder GAD, including maintenance of antianxiety...
Articles 2008-05-08
New Data on SEROQUEL XR™ in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
- Studies Evaluated Improvement in Symptoms Both in the Short and Long Term - WILMINGTON, Del., May 5 /PRNewswire-FirstCall/ -- AstraZeneca today announced new study data on SEROQUEL XRTM quetiapine fumarate Extended-Release Tablets for the treatment of major depressive disorder MDD and generalized anxiety disorder GAD...
Articles 2008-05-05
A Drug That Carries a Lower Risk of Weight Gain Than AstraZeneca's Seroquel and Has Antimanic and Antidepressant Effects Would Earn a 30 Percent Patient Share in Bipolar Disorder Treatment
Seroquel's Successor, Seroquel XR, Will Earn a 16 Percent Patient Share in the Bipolar Disorder Market by 2016, According to a New Report from Decision Resources WALTHAM, Mass., April 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and...
Articles 2008-04-22
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder.
M2 PRESSWIRE-29 February 2008-MB Alerts: AstraZeneca Submits sNDA for SEROQUEL XRTM for the Treatment of Major Depressive DisorderC1994-2008 M2 COMMUNICATIONS LTD RDATE:29022008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial...
Articles 2008-02-29
Seroquel PBS listed.(Clinical report)
Simone Roberts THE PBS listing of Seroquel quetiapine fumarate for acute bipolar mania is welcome news for more than 100,000 patients with bipolar disorder. From 1 December, patients with acute mania associated with bipolar 1 disorder can access Seroquel...
Articles 2007-12-06
AstraZeneca drug approved
Business News IN BRIEF --US health regulators have approved AstraZeneca's Seroquel XR, an extended-release version of one of its top-selling drugs, as a maintenance treatment for adult schizophrenia patients. The basic drug had $3.2bn (1.6bn) revenues in 2006, making it the Anglo- Swedish drug maker's second-biggest...
Articles 2007-11-17
AstraZeneca's Once-Daily SEROQUEL XR(TM) Extended-Release Tablets Approved in Netherlands for the Acute and Long Term Treatment of Schizophrenia.
LONDON, August 29 /PRNewswire/ -- - For International Medical Journalists Only AstraZeneca today announced the Netherlands regulatory authority MEB Medicines Evaluation Board has approved SEROQUEL XRTM quetiapine fumarate Extended-Release Tablets, a once-daily medicine for the treatment of schizophrenia in...
Articles 2007-08-29
Trade Alert for AstraZeneca plc.
M2 PRESSWIRE-11 July 2007-Biotech News: Trade Alert for AstraZeneca plcC1994-2007 M2 COMMUNICATIONS LTD RDATE:11072007 Trade Alert for AstraZeneca plc (NYSE:AZN) AstraZeneca PLC discovers, develops, manufactures, and markets prescription pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory...
Articles 2007-07-11
Zyprexa and other antipsychotic drugs for elderly people with dementia
The frequently prescribed antipsychotic drugs are causing a slight increase in deaths in demented elderly people, according to a study published recently in Annals of Internal Medicine. You might wonder: Why on earth would a doctor prescribe antipsychotics--drugs that are used to treat schizophrenia and bipolar disorders--to a demented elderly...
Articles 2007-07-01
  • << Previous
  • page 1 of 1
  • Next >>